Advertisement

Insulin Antibodies

  • A. Kurtz
Part of the Immunology and Medicine book series (IMME, volume 3)

Abstract

There are several reasons for the continuing interest in the immunological response to insulin. The insulin molecule has been extensively studied and its tertiary structure is fully documented; insulin is the most frequently injected highly purified polypeptide used in medicine, and it is readily available, as are species variants, chemically modified insulins and molecular fragments. Most research over the years has been concerned with the immunological response to injected insulin: usually the production of insulin-binding immunoglobulin G (IgG). The unravelling of the autoimmune nature of the pathology of Type I diabetes has created interest in the occurrence of spontaneous antibodies to insulin.

Keywords

Human Insulin Insulin Antibody Insulin Preparation Solid Phase Method Insulin Molecule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schlichtkrull, J., Brange, J., Christiansen, Aa. H., Hallund, O., Heding, L. G. and Jorgensen, K. H. (1972). Clinical aspects of insulin - antigenicity. Diabetes, Suppl. 2, 649–56.Google Scholar
  2. 2.
    Bloom, S. R., West, A. M., Polak, J. M., Barnes, A. J. and Adrian, T. E. (1978). Hormonal contaminants of insulin. In Bloom, S. R. and Grossman, M. I. (eds.) Gut Hormones, pp. 318–22. (Edinburgh: Churchill Livingstone).Google Scholar
  3. 3.
    Kurtz, A. B., Matthews, J. A., Mustaffa, B. E., Daggett, P. R. and Nabarro, J. D. N. (1980). Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin. Diabetologia, 18, 147–50.PubMedCrossRefGoogle Scholar
  4. Hansen, B., Hoiriis Nielsen, J. and Welinder, B. (1981). Immunogenicity of insulin in relation to its physicochemical properties. In Keck, K. and Erb, P. (eds.) Basic and Clinical Aspects of Immunity to Insulin, pp. 335–52. (Berlin: de Gruyter).Google Scholar
  5. 5.
    Kurtz, A. B. and Nabarro, J. D. N. (1980). Circulating insulin-binding antibodies. Diabetologia, 19, 329–34.PubMedCrossRefGoogle Scholar
  6. 6.
    Banting, F. G., Franks, W. R. and Gairns, S. (1938). Anti-insulin activity of serum of insulin-treated patient. Am. J. Psych., 95, 562–5.Google Scholar
  7. 7.
    Lowell, F. C. (1944). Immunologic studies in insulin resistance. II. The presence of a neutralizing factor in blood exhibiting some characteristics of an antibody. J. Clin. Invest., 23, 233–40.PubMedCrossRefGoogle Scholar
  8. 8.
    Berson, S. A., Yalow, R. S., Bauman, A., Rothschild, M. A. and Newerly, K. (1956). Insulin 1311 metabolism in human subjects. Demonstration of insulin binding globulin in circulation of insulin treated subjects. J. Clin. Invest., 35, 170–90.Google Scholar
  9. 9.
    Oakley, W. G., Jones, V. E. and Cunliffe, A. C. (1967). Insulin resistance. Br. Med. 2, 134–8.CrossRefGoogle Scholar
  10. 10.
    Reeves, W. G. (1983). Insulin antibody determination: theoretical and practical considerations. Diabetologia, 24, 399–403.PubMedCrossRefGoogle Scholar
  11. 11.
    Kurtz, A. B., Reeves, W. G., Smith, W. C. and Spradlin, C. T. (1984). Inter-laboratory insulin antibody workshop: a report of a collaborative study in Europe and the United States. Diabetologia, 27, 300A.Google Scholar
  12. 12.
    Berson, S. A. and Yalow, R. S. (1959). Species-specificity of human anti-beef, pork insulin serum. J. Clin. Invest., 38, 2017–25.PubMedCrossRefGoogle Scholar
  13. 13.
    Kurtz, A. B., Matthews, J. A. and Nabarro, J. D. N. (1978). Insulin-binding antibody: reaction differences with bovine and porcine insulins. Diabetologia, 15, 19–22.PubMedCrossRefGoogle Scholar
  14. 14.
    Devlin, J. G. and Brien, T. G. (1965). Relationship between differential antibody binding capacity and clinical requirements of beef and pork insulin. Metabolism, 14, 1034–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Reeves, W. G. (1985). Immunological aspects of therapy. In Alberti, K. G. M. M. and Krall, L. P. (eds.) The Diabetes Annual. Vol. 1, pp. 67–81. (Amsterdam: Elsevier).Google Scholar
  16. 16.
    Fineberg, S. E., Galloway, J. A., Fineberg, N. S., Rathbun, M. J. and Hufferd, S. (1983). Immunogenicity of recombinant DNA human insulin. Diabetologia, 25, 465.PubMedCrossRefGoogle Scholar
  17. 17.
    Goldman, J., Baldwin, D., Rubenstein, A. H., Klink, D. D., Blackard, W. G., Fisher, L. K., Roe, T. F. and Schnure, J. J. (1979). Characterization of circulating insulin and proinsulin- binding antibodies in autoimmune hypoglycaemia. J. Clin. Invest., 63, 1050–9.PubMedCrossRefGoogle Scholar
  18. Keck, K. (1981). Insulin as a tool for the study of immunological problems. In Keck, K. and Erb, P. (eds.) Basic and Clinical Aspects of Immunity to Insulin, pp. 3–16. (Berlin: de Gruyter).Google Scholar
  19. 19.
    Nakao, Y., Matsumoto, H., Miyazaki, T., Mizuno, N., Arima, N., Wakisaka, A., Okimoto, K., Akazawa, Y., Tsuji, K. and Fujita, T. (1981). IgG heavychain (Gm) allotypes and immune response to insulin-requiring diabetes mellitus. N. Engl. J. Med., 304, 407–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Kurtz, A. B., Gray, R. S., Markanday, S. and Nabarro, J. D. N. (1983). Circulating IgG antibody to protamine in patients treated with protamine-insulins. Diabetologia, 25, 322–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Kurtz, A. B., Di Silvio, L. and Lydyard, P. (1985). Lymphocyte proliferation as a test of the immune response to insulin in diabetics. Diabetes Res., 2, 175–8.PubMedGoogle Scholar
  22. 22.
    Berson, S. A. and Yalow, R. S. (1959). Quantitative aspects of the reaction between insulin and insulin-binding antibody. J. Clin. Invest., 38, 1996–2016.PubMedCrossRefGoogle Scholar
  23. 23.
    Scatchard, G. (1949). The attraction of proteins for small molecules and ions. Ann. N. Y. Acad. Sci., 51, 660–73.CrossRefGoogle Scholar
  24. 24.
    Matsukura, S., West, C. D., Ichikawa, Y., Jubiz, W., Harada, G. and Tyler, F. H. (1971). A new phenomenon of usefulness in the radioimmunoassay of plasma adrenocorticotropic hormone. J. Lab. Clin. Med., 77, 490–500.PubMedGoogle Scholar
  25. 25.
    Weintraub, B. D., Rosen, S., McCammon, J. A. and Perlman, R. L. (1973). Apparent cooperativity in radioimmunoassay of human chorionic gonadotrophin. Endocrinology, 92, 1250–5.PubMedCrossRefGoogle Scholar
  26. Foiling, I. (1976). Insulin anti-insulin complexes. Acta Endocrinol. (Kbh)., (Suppl 205), 199–209.Google Scholar
  27. Schroer, J. (1981). Mouse hybridoma antibody recognition of the insulin molecule. In Keck, K. and Erb, P. (eds.) Basic and Clinical Aspects of Immunity to Insulin, pp. 183–200. (Berlin: de Gruyter).Google Scholar
  28. 28.
    Kurtz, A. B., Harrington, M. G., Matthews, J. A. and Nabarro, J. D. N. (1979). Factitious diabetes and antibody mediated resistance to beef insulin. Diabetologia, 16, 65–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Foiling, I. and Norman, N. (1972). Hyperglycaemia, hypoglycaemia attacks and production of anti-insulin antibodies without previous known immunization. Diabetes, 21, 814–26.Google Scholar
  30. 30.
    Hirata, Y. (1977). Spontaneous insulin antibodies and hypoglycaemia. In Bajaj, J. S. (ed.) Diabetes, pp. 278–84. (Amsterdam: Excerpta Medica).Google Scholar
  31. Kruse, V. (1981). Effect of insulin-binding antibodies on free insulin in plasma and tissue after subcutaneous injection. A model study. In Keck, K. and Erb, P. (eds.) Basic and Clinical Aspects of immunity to Insulin, pp. 319–34. (Berlin: de Gruyter).Google Scholar
  32. 32.
    Nakagawa, S., Suda, N, Kudo, M. and Kawasaki, M. (1973). A new type of hypoglycaemia in a newborn infant. Diabetologia, 9, 367–75.PubMedCrossRefGoogle Scholar
  33. 33.
    Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K. and Paquette, T. L. (1983), Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science, 222, 1337–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Soeldner, J. S., Tuttleman, M., Srikanta, S., Ganda, O. P. and Eisenbarth, G. S. (1985). Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure. N. Engl. J. Med., 313, 893.PubMedCrossRefGoogle Scholar
  35. 35.
    Onodera, T., Ray, U. R., Melez, K. A., Suzuki, H., Tonolio, A. and Notkins, A. L. (1982). Virus-induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression. Nature (London), 297, 66–8.CrossRefGoogle Scholar
  36. 36.
    Benson, E. A., Healy, L. A. and Barron, E. J. (1985). Insulin antibodies in patients receiving penicillamine. Am. J. Med., 78, 857–60.PubMedCrossRefGoogle Scholar
  37. 37.
    Blackshear, P. J., Rofner, H. E., Kriauciunas, K. A. M. and Kahn, C. R. (1983). Reactive hypoglycaemia and insulin autoantibodies in drug induced lupus erythematosus. Ann. Intern. Med., 99, 182–4.PubMedGoogle Scholar
  38. 38.
    Harwood, R. (1960). Insulin-binding antibodies and ‘spontaneous’hypoglycemia. N. Engl. J. Med., 262, 978–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Bolinger, R. E., Morris, J. H., McKnight, F. G. and Diederich, D. A. (1964). Disappearance of 131I-labelled insulin from plasma as a guide to management of diabetes. N. Engl. J. Med., 270, 767–70.PubMedCrossRefGoogle Scholar
  40. 40.
    Vaughan, N. J. A., Matthews, J. A., Kurtz, A. B. and Nabarro, J. D. N. (1983). The bioavailability of circulating antibody-bound insulin following insulin withdrawal in type 1 (insulin-dependent) diabetes. Diabetologia, 24, 355–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Dixon, K., Exon, P. D. and Malins, J. M. (1975). Insulin antibodies and the control of diabetes. Q. J. Med., 44, 543–53.PubMedGoogle Scholar
  42. 42.
    Heding, L. G. (1969). Determination of free and antibody-bound insulin in insulin treated diabetic patients. Horm. Metab. Res., 1, 145–6.PubMedCrossRefGoogle Scholar
  43. 43.
    Nakagawa, S., Nakayama, H., Sasaki, T., Yoshino, K., Yu, Y. Y., Shinozaki, K., Aoki, S. and Mashio, K. (1973). A simple method for the determination of serum free insulin levels in insulin-treated patients. Diabetes, 22, 590–600.PubMedGoogle Scholar
  44. 44.
    Kuzuya, H., Blix, P. M., Horwitz, D. L., Steiner, D. F. and Rubenstein, A. H. (1977). Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes, 26, 22–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Gerbitz, K. D. and Sumner, J. (1981). Distribution of insulin in blood of type 1 diabetics. Diabetologia, 21, 274.Google Scholar
  46. 46.
    Asplin, C. M., Goldie, D. J. and Hartog, M. (1977). The measurement of serum free insulin by steady-state gel filtration. Clin. Chim. Acta, 75, 393–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Nell, L. J., Virta, V. J. and Thomas, J. T. (1985). Application of a rapid enzyme-linked immunosorbent microassay (ELIZA) to study human anti-insulin antibody. Diabetes, 34, 60–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Wide, L. (1973). Clinical significance of measurement of reaginic (IgE) antibody by RAST. Clin. Allergy, 3, 583–95.CrossRefGoogle Scholar
  49. 49.
    Carini, C., Brostoff, J. and Kurtz, A. B. (1982). An anaphylactic reaction to highly purified pork insulin. Confirmation by RAST and RAST inhibition. Diabetologia, 22, 324–6.Google Scholar
  50. 50.
    Karsson, F., Harrison, L. C., Khan, C. R., Itin, A. and Roth, J. (1982). Subpopulations of antibodies directed against evolutionarily conserved regions of the insulin molecule in insulin-treated patients. Diabetologia, 23, 488–93.Google Scholar

Copyright information

© MTP Press Limited 1986

Authors and Affiliations

  • A. Kurtz

There are no affiliations available

Personalised recommendations